Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gastroenterol Clin North Am. 2002 Jun;31(2):421-40, viii.

The epidemic of esophageal adenocarcinoma.

Author information

  • Sections of Gastroenterology and Health Services Research, Houston Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX, USA. hasheme@bcm.tmc.edu

Abstract

The incidence and mortality related to esophageal adenocarcinoma (EAC) have been increasing in the United States, several European countries, and Oceania for the past 2 to 3 decades. Survival remains dismal, with little improvement during the same time period. Variations in the coding, classification, and detection of gastroesophageal malignancy may have contributed partially to the observed trends. Remarkable differences related to gender, ethnicity, and geography characterize the epidemiology of EAC. Gastroesophageal reflux disease (GERD) is the main risk factor for Barrett's esophagus, which is the only known precursor lesion for EAC. Several risk factors that promote the development of GERD and/or Barrett's esophagus have been proposed to explain these rising trends; these factors include the declining rates of Helicobacter pylori infection, obesity, dietary factors, and certain drugs.

PMID:
12134611
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk